Atkinson J G, Girard Y, Rokach J, Rooney C S, McFarlane C S, Rackham A, Share N N
J Med Chem. 1979 Jan;22(1):99-106. doi: 10.1021/jm00187a022.
A series of compounds containing the 3-hydroxy-4H-pyran-4-one nucleus has been synthesized and tested as potential skeletal muscle relaxants. Reduction of 2-(azidomethyl)-5-hydroxy-4H-pyran-4-one (4) with HBr in HOAc--phenol yielded 2-(aminomethyl)-5-hydroxy-4H-pyran-4-one (kojic amine, 3) in 81% yield. Reaction of 2-[(tosyloxy)-methyl]-5-(benzyloxy)-4H-pyran-4-one (5) with NH3 gave a 40% yield of the O-benzyl ether of kojic amine, which was N-acylated with a series of carbobenzyloxy-protected amino acids. Complete deprotection with HBr--HOAc gave the following amino acid amides of kojic amine: glycyl (23), alpha-alanyl (24), beta-alanyl (25), gamma-aminobutyryl (26), and glycylglycyl (27). Among the analogues of kojic amine prepared was a series of one-carbon homologues: 2-[(methylamino)methyl]-5-hydroxy-4H-pyran-4-one (7a), 2-(1-aminoethyl)-5-hydroxy-4H-pyran-4-one (8), 6-(aminomethyl)-3-hydroxy-2-methyl-4H-pyran-4-one (12), and 2-(2-aminoethyl)-5-hydroxy-4H-pyran-4-one (16). Kojic amine (3) has been found to possess certain of the properties to be expected in a gamma-aminobutyric acid mimetic agent, notably skeletal muscle relaxant activity. In the chronic spinal cat preparation, ED70 values for reduction of flexor spasms of 2.2 and 4.0 mg/kg by iv and po routes of administration, respectively, were observed for kojic amine, which was the most potent of the various hydroxypyrone derivatives investigated.
已合成了一系列含有3-羟基-4H-吡喃-4-酮核的化合物,并作为潜在的骨骼肌松弛剂进行了测试。在醋酸 - 苯酚中用氢溴酸还原2-(叠氮甲基)-5-羟基-4H-吡喃-4-酮(4),以81%的产率得到2-(氨基甲基)-5-羟基-4H-吡喃-4-酮(曲酸胺,3)。2-[(对甲苯磺酰氧基)甲基]-5-(苄氧基)-4H-吡喃-4-酮(5)与氨反应,以40%的产率得到曲酸胺的O-苄基醚,其用一系列苄氧羰基保护的氨基酸进行N-酰化。用氢溴酸 - 醋酸完全脱保护得到以下曲酸胺的氨基酸酰胺:甘氨酰(23)、α-丙氨酰(24)、β-丙氨酰(25)、γ-氨基丁酰(26)和甘氨酰甘氨酰(27)。在所制备的曲酸胺类似物中,有一系列一碳同系物:2-[(甲氨基)甲基]-5-羟基-4H-吡喃-4-酮(7a)、2-(1-氨基乙基)-5-羟基-4H-吡喃-4-酮(8)、6-(氨基甲基)-3-羟基-2-甲基-4H-吡喃-4-酮(12)和2-(2-氨基乙基)-5-羟基-4H-吡喃-4-酮(16)。已发现曲酸胺(3)具有γ-氨基丁酸模拟剂预期的某些性质,特别是骨骼肌松弛活性。在慢性脊髓猫制备中,曲酸胺通过静脉注射和口服途径给药时,减少屈肌痉挛的ED70值分别为2.2和4.0mg/kg,曲酸胺是所研究的各种羟基吡喃衍生物中最有效的。